In February, the URAC Board approved development of a new accreditation addressing home infusion therapy. The program is an important step for URAC as we build on our success with specialty pharmacy accreditation.

A group of URAC leaders and managers have spent several months reviewing URAC’s approach to delegation. Members of the Review Team and Account Management Staff provided valuable insight enabling capture of strengths and weaknesses in the standards and our validation methods.

URAC has discovered a great deal about telehealth practice from the depth of expertise provided by our well-known, well-established beta test applicants.